Highlights
About
Neuromodulation Therapy for Urge Urinary Incontinence
BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy for urge urinary incontinence (UUI).
The company developed Revi. Its advanced implant design allows for the device to be miniature in size without the need for replacement surgeries for battery change, lead migration, or lead fracture. Its innovative external wearable technology powers the implant for a patient-centric approach to therapy allowing for increases in energy and stimulation sessions based on the patients’ needs, giving patients the flexibility to ensure the best possible outcome.
BlueWind Medical has successfully completed several clinical studies with excellent results and is focused on bringing its implantable tibial neuromodulation system for the treatment of urge urinary incontinence to the market.
BlueWind Medical was founded by the Rainbow Medical Group.
Identity
| Name | BlueWind Medical |
|---|---|
| Slug | bluewind-medical |
| Type / kind | startup |
| Crunchbase ID | bluewind-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6k-7sJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Herzliya |
| HQ address | Maskit Street 6, Herzliya, Israel |
Web & social
Classifications
Funding
| Total raised | $64.0M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}